Worldwide, tuberculosis (TB) remains one of the top 10 causes of death, killing around 1.4 million people per year. An effective vaccine for TB is one of the primary goals of the VALIDATE Network, an international research network aiming to accelerate vaccine development for complex intracellular pathogens that are often neglected. The VALIDATE Network’s TB vaccine work has now received a $1.5 million funding boost from the Gates Foundation.
Vaccine for TB receives a $1.5 million funding boost
Awards and Appointments General Research
20 August 2021
The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.
